You are here

Folotyn

Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?

Fierce Biotech

Sun, 01/3/21 - 04:29 pm

Gilead Sciences

Acrotech Biopharma

Tiny Biotech With Three Cancer Drugs Is More Alluring Takeover Bet Now

Forbes

Mon, 07/15/13 - 11:14 am

Spectrum Pharmaceuticals

Five More Years of Patent Protection, and Revenue, for Spectrum Pharmaceuticals

Yahoo/Reuters

Mon, 10/8/12 - 10:53 am

Spectrum Pharmaceuticals

peripheral T-cell lymphoma

Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug

Yahoo/AP

Tue, 01/31/12 - 07:56 am

Allos Therapeutics Starts Cancer Study

Yahoo/Zacks.com

Fri, 08/19/11 - 09:10 am

Amag Pharmaceuticals

T-cell lymphoma

Allos Therapeutics Evenly Poised

Yahoo/Zacks.com

Thu, 03/31/11 - 10:43 am

T-cell lymphoma

Allos: analysis shows lymphoma drug helped some patients who didn't respond to other therapies

Yahoo/AP

Thu, 01/20/11 - 02:15 pm

Allos gets added orphan drug status for Folotyn

Yahoo/AP

Fri, 10/15/10 - 12:29 pm

Hodgkin's lymphoma

Allos Therapeutics' Folotyn meets study goal

Yahoo/AP

Wed, 07/28/10 - 11:24 pm

Allos Presents Early-stage Data

Yahoo/Zacks.com

Tue, 06/15/10 - 08:35 am

Introducing the $30,000 Per Month Cancer Drug

WSJ Online

Mon, 12/7/09 - 12:21 pm

Patent issued for Allos Therapeutics' cancer drug Folotyn

Bizjournals.com

Mon, 11/30/09 - 10:34 am

Allos Therapeutics' cancer drug Folotyn now for sale

Bizjournals.com

Mon, 10/5/09 - 10:57 am

FDA Approves Allos Lymphoma Drug

TheStreet.com

Fri, 09/25/09 - 08:38 am

Allos Therapeutics: Prospects for FDA Approval of Folotyn Are Healthy

Seeking Alpha

Fri, 09/4/09 - 07:12 am

Panel Backing for Allos' Drug

Yahoo/Zacks.com

Thu, 09/3/09 - 02:04 pm